This conversation contains the first half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, during which the two discuss what Jeff considered the key strategic takeaways for GLI from the various EASL Congress presentations, abstracts and discussions. Jeff focuses on the "overriding sense of optimism" coming from the multiple pieces of positive drug data. He cites the data on Boehringer Ingelheim's survodutide, the follow-up work on Madri...

Podden och tillhörande omslagsbild på den här sidan tillhör SurfingNASH.com. Innehållet i podden är skapat av SurfingNASH.com och inte av, eller tillsammans med, Poddtoppen.